VEGFA and neoplasm: These effects are even more powerful when agents are used in combination, as shown by Mainetti et al. [18] in an in vivo model of mammary adenocarcinoma treated with a combination of doxorubicin and cyclophosphamide: they observed a reduction of VEGF and an inhibition of tumor growth and metastases.